Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

by February 24, 2025
February 24, 2025
National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

A watchdog group focused on getting diversity, equity and inclusion (DEI) out of medicine found that the National Cancer Institute (NCI) is actively spending millions of grant dollars to boost the number of racial minorities in the cancer workforce. 

This funding, uncovered by the nonprofit watchdog Do No Harm, shows that $218 million in NCI grants for ‘underrepresented’ groups – mainly racial minorities – is actively dispersed by the NCI. Prior to President Donald Trump taking office, during the Biden administration, around 3% of the NCI’s total grant funding every year went to institutions so that they can hire more faculty members and scientists who are minorities, according to Do No Harm.

The revelation comes as Elon Musk’s DOGE puts a slew of funds related to DEI on the chopping block amid efforts to slim down government spending. Trump and fellow Republicans have pushed hard against DEI policies throughout the government in recent weeks, making the case that public programs should instead focus on meritocracy. 

Among the NCI’s DEI grants that remain active under Trump are two totaling more than $10.5 million, awarded to the Icahn School of Medicine at Mount Sinai. These grants support hiring initiatives aimed at ‘inclusive excellence’ and programs that promote advancing the careers of racial minorities.

One of the grant’s descriptions explicitly calls for the recruitment of 12 scientists from ‘underrepresented groups,’ while the other grant’s description includes, alongside its recruitment and hiring goals, a plan to ‘modify the Mount Sinai Health System Task Force To Address Racism Roadmap for Change with key strategies as the basis for an Icahn School of Medicine at Mount Sinai Roadmap for Inclusive Excellence.’ 

In a statement to Fox News Digital, Do No Harm Chairman Dr. Stanley Goldfarb said the NCI must ‘stop promoting a politically motivated DEI agenda.’

‘The National Cancer Institute has been taking advantage of taxpayers to push a DEI agenda on the medical field,’ Goldfarb said. ‘They dole out $218 million each year for grants prioritizing ‘underrepresented’ in medicine, which has generally been defined as anyone from a racial minority group, except Asian Americans. The National Cancer Institute should not be rewarding racial discrimination with taxpayer money. Racial discrimination has no place in medicine.’

Under former President Joe Biden, the NCI’s website was filled with statements and sources about programs tied to DEI, but, following Trump’s executive order demanding an end to DEI in the federal government, much of that has come down. Fox News Digital reached out to the NCI to question whether it had any plans to terminate any of its active grants promoting DEI hiring, but did not receive a response by press time. 

Fox News Digital also inquired about the sub-agency’s Equity Council, established in 2021 under Biden, but did not receive a response. The council is a steering committee for the NCI’s equity and inclusion efforts.

DOGE claims it has already addressed hundreds of millions of taxpayer dollars in DEI-related contract cuts, including $350 million at the Department of Education. 

Last month, DOGE announced that taxpayers would see just over $1 billion in savings through the elimination of 104 DEI contracts.

This post appeared first on FOX NEWS
previous post
Trump announces Dan Bongino will be deputy director of the FBI
next post
‘Escape poverty’: Millions more food stamp recipients required to work under new House GOP proposal

Related Posts

Trump health secretary nominee RFK Jr survives heated...

January 31, 2025

GOP senator sends warning to Biden admin about...

November 5, 2024

Top Biden ally ‘disappointed’ by president’s veto on...

December 24, 2024

State Department criticizes Israel’s attempts at ‘mitigating civilian...

May 11, 2024

Trump to put tariff exemptions on certain goods...

March 7, 2025

Bondi spars with Schiff at testy confirmation hearing:...

January 16, 2025

‘I’ve never seen this’: Top Republican details level of Secret...

September 19, 2024

FBI must release Mar-a-Lago probe records despite Trump’s...

February 11, 2025

DAVID MARCUS: ‘Hamilton’ cancels itself as the Left...

March 6, 2025

Trump’s trade representative pick to appear before Senate...

February 6, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Trump pushes ‘Big, Beautiful Bill’ as solution to four years of Biden failures: ‘Largest tax cut, EVER’

      June 3, 2025
    • Trump administration open to allowing Iran to continue some uranium enrichment: report

      June 3, 2025
    • ‘Squad’ members condemn antisemitic attack in Boulder after years of controversy

      June 2, 2025
    • Schumer, Democrats plot coordinated resistance to Trump’s ‘one ugly bill’

      June 2, 2025
    • Tariff fight escalates as Trump appeals second court loss

      June 2, 2025
    • SCOOP: House Freedom Caucus draws battle lines as White House readies $9.4B DOGE spending cuts

      June 2, 2025

    Categories

    • Business (1,238)
    • Politics (5,799)
    • Stocks (904)
    • World News (457)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved